Literature DB >> 20847569

Demographic and clinical characteristics of patients with autosomal dominant polycystic kidney disease: a multicenter experience.

Rumeyza Kazancioglu1, Tevfik Ecder, Lutfullah Altintepe, Mehmet Riza Altiparmak, Serhan Tuglular, Abdullah Uyanik, Caner Cavdar, Sabahat Alisir Ecder, Bulent Tokgoz, Neval Duman, Ali Duzova, Ramazan Cetinkaya.   

Abstract

AIM: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. It accounts for 5-10% of patients with end-stage renal disease (ESRD). The aim of this multicenter study was to investigate the demographic and clinical characteristics of patients with ADPKD.
METHODS: 1,139 patients with ADPKD who were followed up at 12 different centers were recruited for this study. The investigated demographic and clinical characteristics were gender, age, smoking history, educational status, the existence of hypertension, hematuria, urinary tract infection, urinary tract stones and renal replacement therapy. Patients were considered as hypertensive if they were taking antihypertensive medications or if they had blood pressure (BP) of 140/90 mm Hg or greater. If the patients were currently on antihypertensive drugs, the classes of these agents were noted.
RESULTS: 548 male and 591 female patients were included and the mean age at initial diagnosis was 37.1 ± 16.3 years. 20.3% were current smokers whereas 15% were ex-smokers. The mean systolic and diastolic BPs were 136.1 ± 29.8 and 84.9 ± 17.8 mm Hg, respectively. 63.7% used antihypertensive drugs and 73.1% of those used renin-angiotensin system blockers. 11.8% had ESRD, of which 75.8% were treated with hemodialysis.
CONCLUSION: This study showed that hypertension is the most common (72.6%) clinical finding in ADPKD patients in Turkey and renin-angiotensin system blockers are widely used.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20847569     DOI: 10.1159/000320745

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  5 in total

1.  Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience.

Authors:  Abdullah Ozkok; Timur Selcuk Akpinar; Fatih Tufan; Nilufer Alpay Kanitez; Mukremin Uysal; Metban Guzel; Yasar Caliskan; Sabahat Alisir; Halil Yazici; Tevfik Ecder
Journal:  Clin Exp Nephrol       Date:  2012-10-20       Impact factor: 2.801

2.  RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.

Authors:  Hyunjin Ryu; Hayne C Park; Yun Kyu Oh; Irene Sangadi; Annette Wong; Changlin Mei; Tevfik Ecder; Angela Yee-Moon Wang; Tze-Wah Kao; Jenq-Wen Huang; Gopala K Rangan; Curie Ahn
Journal:  BMJ Open       Date:  2020-02-06       Impact factor: 2.692

3.  Endothelial Dysfunction and Atherosclerosis in Patients With Autosomal Dominant Polycystic Kidney Disease.

Authors:  İskender Ekinci; Mitat Buyukkaba; Ahmet Cinar; Muhammed Tunc; Egemen Cebeci; Meltem Gursu; Rumeyza Kazancioglu
Journal:  Cureus       Date:  2021-02-25

4.  Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana.

Authors:  Perditer Okyere; Richard K D Ephraim; Isaac Okyere; Joseph Attakorah; Dorcas Serwaa; Grace Essuman; Albert Abaka-Yawson; Prince Adoba
Journal:  BMC Nephrol       Date:  2021-04-28       Impact factor: 2.388

5.  Stone Prevalence in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Vinusha Kalatharan; Gary Grewal; Danielle M Nash; Blayne Welk; Sisira Sarma; York Pei; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2020-07-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.